BPS2110 Midterm 2 slides 1

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/27

encourage image

There's no tags or description

Looks like no tags are added yet.

28 Terms

1
New cards

Non covalent intereractions between drugs and binding

Electrostatic

Hydrogen bonding

Dipole Dipole

Van der Waals

2
New cards

Electrostatic interactions

Occur between oppositely charged groups

Strength depends on the surrounding environment, interactions can be stronger when buried away from water

Non-directional

3
New cards

Hydrogen bonds

specialized dipole dipole interactions

strength depends on surrounding environment (eg. hydrophobic environment)

highly directional, strength depends on geometry between donor and acceptor

requires donor and acceptor

Donor provides hydrogen eg OH, NH

Acceptor provides lone pair of e- eg. O, N

4
New cards

Dipole-Dipole

occurs between partial negative and partial positive charges of polar molecules

arise from differences in e-ivity between bonded atom, directional

strength depends on distance, orientation and surroundings

can be stronger in hydrophobic/less polar enviro

common in functional groups with strong dipoles eg. carbonyl

5
New cards

Van der Waals (disperson)


weak interactions, arise from temporary fluctuations in electron distribution, that create instantaneous dipoles.

Occur when atoms or molecular surfaces are in close contact, are non directional

strength increases with the amount of surface contact

Many weak interactions together can make an important contribution to drug–target binding Particularly important when a drug fits closely within a binding pocket

6
New cards

Desolvation during drug binding

When a drug is dissolved in the body, water molecules surround it

during binding: water molecules surrounding the drug and occupying the binding site must be pushed out

The interactions between water and the drug help stabilize the drug, so removing the interactions requires energy (energetic cost of desolvation)

Drug binding depends on whether new interactions with the target compensate for the interactions lost with water.

  • If the drug loses favourable interactions with water but forms even stronger interactions with the protein → binding is favourable.

  • If the drug loses favourable interactions with water but forms weak interactions with the protein → binding may not be favourable


7
New cards

Measuring Drug activity:

drug activity is measured using biological assay

  • experiment used to measure effect of drug on biological system

Assays can provide:

  • Qualitative info (whether effect occurs)

  • Quantitative info (magnitude of effect, eg decrease inflammation by 20%

  • Can be performed in vitro (outside whole living organism) or in vivo (inside living organism)

Assay selected depends on question


8
New cards

Types of Assays

different assays measure drug activity at different levels

Biochemical

Cell based

Tissue based

9
New cards

Biochemical assay:

  • Use purified targets or isolated biological components.

  • Measure how a drug interacts with a specific molecule, such as an enzyme.

  • Example: Does the drug inhibit an enzyme's activity?


10
New cards

cell based assay

  • Use intact, living cells.

  • Measure how cells respond when exposed to a drug.

  • Example: Does the drug prevent cancer cells from multiplying?


11
New cards

Tissue based assay

  • Use tissues containing multiple cells organized together.

  • Measure drug responses in a more complex biological environment.

  • Example: Does a drug cause a piece of heart tissue to contract less strongly?


12
New cards

potency

describes amount or concentration of drug required to produce a specified effect

Lower concentration/dose required → greater potency

Not the same as maximum effect (efficacy)

13
New cards

SAR

structure-activity relationships

how does changing structure affect drugs biological activity

  1. Start with an active compound (a molecule that already produces a desired biological effect).

  2. Make a structural modification (change part of the molecule).

  3. Measure its biological activity using an assay.

  4. Compare its activity with the original compound and other modified compounds.

  5. Determine whether the structural change improved or reduced activity

identify which structural features are important for biological activity

14
New cards

SPR

Structure-Property Relationships (SPR)

how changing molecular structure affects physiochemical (eg. solubility, stability) and pharmacokinetic properties (eg. absorption, metabolism, excretion)

SPR and SAR are optimized together!!!

  • a molecule could have excelled biological activity but be unsuitable for development because: it didn’t dissolve well in water, gets metabolized too quickly, etc.)


15
New cards

what is meant by the term “drug like? what challenges are associated with designing a drug like compound

sufficient bio activity (potent enough to produce desired effect)

Selectivity – Preferential activity at the intended target

Suitable physicochemical properties (solubility, permeability)

Suitable biological properties (metabolic stability, ability to reach target)

Practical to develop (feasible synthesis, usable dosage form)

challenge: balancing properties that often have opposing effecs.

16
New cards

Common drug property measurements

Aqueous solubility: ability to dissolve in water •

pKa: tendency of an ionizable group to gain or lose aproton •

LogP / LogD: measures of lipophilicity •

Molecular weight: molecular size •

Permeability: ability to cross a biological barrier •

Melting point: related to solid-state properties andsolubility •

Metabolic stability: susceptibility to metabolism•

Protein binding: extent of drug binding to proteins

17
New cards

Property optimization

A drug will encounter many biological barriers before it can reach its target

biological activity and drug properties must be optimized to influence its ability to cross those barriers and reach target

Not all molecules in a dose reach bio target, so drug properties influence how much passes each barrier

18
New cards

water environment

polar

forms hydrogen bonding and dipole dipole interactions

hydrophilic molecules interact favourably

19
New cards

lipid/hydrocarbon environment

Non polar

No significant partial positive or negative charges, so polar interactions are limited. Main attractive force is van der waals

lipophilic/hydrophobic molecules interact favourably

20
New cards

DRAW THEM

  • membrane phospholipid

  • equations for pKa


21
New cards

membrane permeability

Many molecules can cross lipid bilayers by passive diffusion

interior of lipid bilayer is non polar, so drug must enter lipid environment to cross membrane

drug must be sufficiently water soluble to dissolve in aqueous biological fluids, BUT also have sufficient membrane permeability

successful drugs have appropriate balance

22
New cards

Ionization and solubility

many drugs contain acidic or basic functional groups that can exist in ionized (charged) or neutral forms

ionizable groups can gain or lose proton

Ionized forms more water-soluble

neutral forms cross membranes more readily by passive diffusion

proportion of each form depends on pH and pKa

Approximately 75% of drugs are basic, 20% acidic, and 5% neutral/non-ionizable.

23
New cards

pKa vs pH

pH describes acidity of surrounding solution (low pH = high H+ concentration)

pKa describes how easily an ionizable group gives up a proton (low pKa, group readily loses H aka strong acid), a characteristic

comparing pH and pKa helps predict whether a group is predominantly protonated or deprotonated


24
New cards

Acids vs Bases, Protonation

Acids: proton donor

pH < pKa (environment has relatively more H, so acid keeps its proton) NEUTRAL

when pH > pKa (environment has relatively less H+, so acid loses its proton), NEGATIVELY CHARGED

base: proton acceptor

pH < pKa (CA) environment has more H+, protonated base keeps its proton. POSITIVELY CHARGED

pH > pKa (CA) environment has less H+, so protonated base loses its proton. NEUTRAL





neutral when pH < pKa, charged when pH > pKa

Bases: neutral when pH> pKa (of cb), charged when pH < pKa

25
New cards

Amphiprotic

certain functional groups can act as acid or base depending on chemical environment

26
New cards

Aqueous pH

Drug ionization occurs in an aqueous environment, which limits pH range relevant to drug development conditions

H3O+: pKa ~ 1.7 (BASE)

H2OL pKA ~ 15.7 (ACID)

Imagine a drug with an ionizable group with a pKa of 30. the pH conditions normally encountered in the body wont cause it to change its ionization state.

if pKa is far outside aqueous range, ionization is not relevant.


27
New cards

why do molecules with permanent charges problematic for drug delivery

do not cross membranes easily

are eliminated quiclky by kidneys

28
New cards

Why are weak acids or bases generally more suitable as drugs than strong acids or bases?

The pKa values of weak acids and bases are typically close to physiological pH (around 7), so at pH 7 there is always a small fraction of the drug in its neutral form, which can cross biological membranes more easily. In contrast, strong acids and bases are almost fully ionized at all physiological pH values, leaving very little of the neutral form available. As a result, their ability to cross membranes is greatly reduced and absorption becomes slow or inefficient